Pharma and Biotech
TR-1: Notification of major holdings | 22-Apr-2024 | 17:45 | RNS |
Result of GM, Cancellation of Admission to Trading | 19-Apr-2024 | 12:18 | RNS |
Share Purchases by a Director | 18-Apr-2024 | 07:00 | RNS |
Share Purchase by a Director | 12-Apr-2024 | 07:00 | RNS |
Update on Broking Arrangements | 10-Apr-2024 | 07:00 | RNS |
TR-1: Notification of major holdings | 08-Apr-2024 | 15:32 | RNS |
Proposed Cancellation of Admission to Trading | 02-Apr-2024 | 07:00 | RNS |
Result of AGM | 14-Mar-2024 | 11:27 | RNS |
Redx to Exhibit Three Posters at AACR | 06-Mar-2024 | 07:00 | RNS |
First Participant Dosed in Phase 1 Trial of RXC008 | 28-Feb-2024 | 07:00 | RNS |
New Grant of Options | 23-Feb-2024 | 07:00 | RNS |
Notice of AGM | 16-Feb-2024 | 16:50 | RNS |
Statement re Press Report | 14-Feb-2024 | 07:00 | RNS |
TR-1: Notification of major holdings | 08-Feb-2024 | 13:02 | RNS |
Redx announces sale of KRAS inhibitor program | 07-Feb-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 9.00p |
Change Today | -0.25p |
% Change | -2.70 % |
52 Week High | 36.00 |
52 Week Low | 4.25 |
Volume | 469,167 |
Shares Issued | 388.99m |
Market Cap | £35.01m |
RiskGrade | 278 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:23 | 25,000 @ 8.21p |
16:04 | 2,445 @ 8.21p |
16:01 | 150 @ 8.20p |
16:01 | 123 @ 8.20p |
16:01 | 9,990 @ 8.20p |
You are here: research